Market Tracker

09/26 4:45pm ET

Cascadian Therapeutics Inc (NASDAQ:CASC)

1.59
Delayed Data
As of Sep 26
 +0.19 / +13.57%
Today’s Change
0.82
Today|||52-Week Range
3.75
-28.38%
Year-to-Date
No recent news for Cascadian Therapeutics Inc.

Today’s Trading

Previous close1.40
Today’s open1.40
Day’s range1.37 - 1.66
Volume2,006,251
Average volume (3 months)858,100
Market cap$189.4M
Dividend yield--
Data as of 3:59pm ET, 09/26/2016

Growth & Valuation

Earnings growth (last year)+46.88%
Earnings growth (this year)-50.98%
Earnings growth (next 5 years)+0.20%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
CDXSCodexis Inc-0.05-1.17%
NVIVInVivo Therapeutics ...+0.01+0.15%
PRTOProteon Therapeutics...-0.59-6.11%
AVXLAnavex Life Sciences...+0.04+1.29%
Data as of 3:59pm ET, 09/26/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$0.00
Annual profit (last year)-$32.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Scott D. Myers
Chief Operating Officer
Gary W. Christianson
Corporate headquarters
Seattle, Washington

Forecasts